Heart disease is more common in people over 65, but treatments are better than ever. That can...
Author - David Miller
DEA Pharmacy Decision Highlights Agency’s Thinking on Expert...
By Andrew J. Hull — A recent DEA decision revoking the registration of a Louisiana pharmacy sheds...
Opinion: ‘Ultra-processed food’ is too broad a term to be...
In recent years, an idea has taken hold across the ideological spectrum: The rise in diabetes and...
Adopting Flexible Strategies to Combat Capacity Shortages
More and more contract manufacturers have been looking not at what the state of the supply chain is...
Covid, inflation, and Supreme Court blamed for steep drop in...
The tiny number of Indigenous students in U.S. medical schools has long been a concern, but Native...
IMU-856: A Potential Solution for Celiac Patients Facing...
Daniel Vitt, CEO, Immunic Therapeutics, discusses how IMU-856 could support the challenges of...
From Oral Medication to Liquid: Q&A with Michael Demurjian
The CEO discusses his company’s platform that helps reformulate oral solid dose medications to...
Decades of LDT Tension Leads to an Epic Three-Hour Oral Argument
By Allyson B. Mullen & Jeffrey N. Gibbs — The multi-decade battle over FDA’s power to regulate...
Ladrones de Ozempic: la nueva ola delictiva en Brasil
En un país obsesionado con la imagen corporal, bandas delictivas roban medicamentos para perder...
FDA Approves Prolacta Bioscience’s Surgifort for Infants...
Surgifort is the first FDA-approved human milk-based fortifier specifically designed for term...